UK DRI Grand Challenge: developing a functional circuit biomarker for Alzheimer’s disease
With emerging treatments for Alzheimer's on the horizon, it is critical that people can be diagnosed early in the disease for intervention to be most effective. To aid this, scientists are looking to 'biomarkers’ - biological measures or ‘signposts’. In this new UK DRI Grand Challenge, Dr Marc Aurel Busche and a team of collaborators will carry out animal and human studies in parallel, to develop a new functional biomarker for Alzheimer's that measures subtle changes to the brain’s circuitry in the earliest stages of disease.
Read Article